Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Interleukin Genetics, Inc. (OTCQB: ILIU) today issued financial and operational results for the second quarter ended June 30, 2013.
Revenue for the quarter ended June 30, 2013 was $852,000, compared to $799,000 for the same period in 2012. The increase is primarily attributable to increased genetic testing revenue recognized from genetic tests processed as a result of sales through the Amway sales channel.
Hey, check out all the research scientist jobs. Post your resume today!
